# Evvy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evvy

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.evvy.com
- Total disclosed funding: $59M
- Latest round: Series B (Sep 15, 2026)
- Investors on record: 17

## About

Based in New York, US, and founded in 2020, Allora Health Inc. doing business as Evvy operates as a female technology company focusing on women's health. The company was co-founded by (CEO) Priyanka Jai, (CMO) Laine Bruzek and Pitta Navarro(CSO) . In September 2026, Evvy raised USD 40 million in series B funding led by Catalio Capital Management, with participation from US Fertility, Rethink Capital Partners, Muse Capital, Alumni Ventures Group, LabCorp Ventures, General Catalyst Partners, Left Lane Capital, Foreground Capital, BBG Ventures, Ingeborg Investments, and Amboy Street Ventures.

Evvy offers a vaginal microbiome test leveraging metagenomic sequencing to demystify Yeast Infections, BV, Chronic UTIs, the vaginal microbiome, and overall female health. The company provides a personalized wellness plan after the vaginal microbiome test. The test results are delivered back after 2 weeks in a personal private online dashboard with the actionable results. Evvy also offers flags research that linking imbalances in the vaginal microbiome to more serious issues like infertility or pre-term birth that even linkages to the progression of cervical cancer.

Evvy generates revenue on a commercial service paying by its users.

The company plans to use the September 2026 funding to validate new AI-driven diagnostic and care models for women’s health, starting with fertility, expand distribution through physician and partner channels, and strengthen its collaboration with US Fertility.

## Funding rounds

- Series B, Sep 15, 2026, $40M — General Catalyst Partners, Rethink Capital Partners, Alumni Ventures Group, BBG Ventures, Muse Capital, LabCorp Ventures, Left Lane Capital, US Fertility, Catalio Capital Management, Amboy Street Ventures, Ingeborg Investments, Foreground Capital
- Series A, Sep 27, 2023, $14M — General Catalyst Partners, RH Capital Partners, LabCorp Ventures, Virtue Labs, LLC, Left Lane Capital, G9 Ventures, Amboy Street Ventures, Ingeborg Investments
- Seed, Jul 14, 2021, $5M — General Catalyst Partners, BoxGroup, BBG Ventures, Human Ventures, Virtue Labs, LLC, G9 Ventures

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed, Series A, Series B
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Seed
- BBG Ventures (https://capitalatlas.ai/funds/bbg-ventures) — Seed, Series B
- Human Ventures — Seed
- Virtue Labs, LLC — Seed, Series A
- G9 Ventures (https://capitalatlas.ai/funds/g9-ventures) — Seed, Series A
- RH Capital Partners (https://capitalatlas.ai/funds/rh-capital-partners) — Series A
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series A, Series B
- Left Lane Capital (https://capitalatlas.ai/funds/left-lane-capital) — Series A, Series B
- Amboy Street Ventures (https://capitalatlas.ai/funds/amboy-street-ventures) — Series A, Series B
- Ingeborg Investments (https://capitalatlas.ai/funds/ingeborg-investments) — Series A, Series B
- Rethink Capital Partners (https://capitalatlas.ai/funds/rethink-capital-partners) — Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B
- Muse Capital (https://capitalatlas.ai/funds/muse-capital) — Series B
- US Fertility — Series B
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series B
- Foreground Capital (https://capitalatlas.ai/funds/foreground-capital) — Series B